USPTO Deadlines
Next Deadline
2177 days remaining
Section 8 Declaration Due (Principal Register)
Due Date
January 20, 2032
Grace Period Ends
July 20, 2032
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 20, 2026 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 20, 2026 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 2, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 2, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 30, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 30, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 29, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 29, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 16, 2025 | GAUN | O | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | Loading... |
| Oct 16, 2025 | GAUD | O | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | Loading... |
| Oct 16, 2025 | NAUD | R | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | Loading... |
| Oct 8, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 30, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 30, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 4, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 4, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 4, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 4, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 3, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 3, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 3, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vaccine adjuvants; Adjuvants for medical purposes; Adjuvants for use with vaccines; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Human vaccine preparations; Oral vaccine preparations; Herbal supplements; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Mixed biological preparations for the prevention and treatment of infectious diseases; Plant extracts, other than essential oils, for pharmaceutical purposes; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes
First Use Anywhere:
Mar 15, 2023
First Use in Commerce:
Mar 15, 2023
Classification
International Classes
005